Axitinib
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1932 publications
Hybridization of isatin and benzoxazolinone via a diethyl spacer: a new scaffold for breast cancer drug discovery.
Journal: Future medicinal chemistry
Published: June 11, 2026
Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma.
Journal: JAMA network open
Published: May 21, 2026
A novel hyperactive BCR::ABL1 e6a3 variant confers resistance to combined asciminib plus ponatinib therapy.
Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026
Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
Journal: JCO global oncology
Published: April 10, 2026
A systematic review on clinical pharmacokinetics and pharmacodynamics of antiangiogenic tyrosine kinase inhibitors (TKIs) with high TDM scores.
Journal: Expert review of anticancer therapy
Published: April 08, 2026
Renal clear cell carcinoma with co-existing tumor thrombosis of renal vein and ureter: a case report and review of the literature.
Journal: Frontiers in oncology
Published: April 01, 2026
Unclear territory: navigating metastatic nonclear cell renal cell carcinoma.
Journal: Current opinion in oncology
Published: March 24, 2026
Re: Fecal Microbiota Transplantation plus Pembrolizumab and Axitinib in Metastatic Renal Cell Carcinoma: The Randomized Phase 2 TACITO Trial.
Journal: European urology
Published: March 11, 2026
Last Updated: 06/30/2026